Prospective Phase II Study for Assessment of Regulatory Immune Cell Populations After Allogeneic HSCT

NCT00587574 · clinicaltrials.gov ↗

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Allogeneic Hematopoietic Cell Transplant Recipients

Sponsor

Medical University of Vienna